accordance with the Company’s target to consistently launch new service projects every year. However, due to the uncertainty of the merger situation of mobile operators during this period, as a result, each
Limited for the three months period ended March 31, 2019. And The Audited financial statement of BS Myco Biotech Company Limited for year ended December 31,2018. The calculation of transaction size (1) Book
period ended 30 September 2018. Assets At the end of year 2016 and 20017, the Group Company presented total assets of THB 311.69 million and THB 302.49 million, respectively. Major assets are property
outstanding period of more than 12 months in the financial statements. The affected lease contracts related to the lease of space of advertising, office building space, motor vehicles and equipment. ASSETS
3,924 3,514 -10% -27% 18,157 16,655 -8% Profit before tax income 1,370 1,333 1,419 12% 9% 5,144 4,647 -10% Income tax expenses 271 297 231 -22% -15% 1,024 967 -6% Net profit for the period 1,055 1,009
, a director or an executive to elucidate or disclose additional information within the specified period, and order a foreign company to suspend the offer for sale of shares until clarification and
8.7% and net profit stood at THB 11,738 mn, an increase of 4.7% from the same period in the previous year (YoY). The shopping mall business, which is the Company’s core business, continues to perform
launched KK SME3X, a new financial product focusing on small and medium-sized enterprises, using property as collateral with maximum credit line of three times the collateral value with maximum loan amount
to the Notification of Acquisition or Disposition of Assets and refer to the consolidated financial statements of the Company for the 6 months period ended 31 December 2017. And the consolidated